PHARMA
JHL Biotech Partners Sanofi For Biologics In China
Sanofi and JHL Biotech have formed a strategic alliance to develop and commercialize biological therapeutics for the Chinese market.
Novogene Completes US$75 Million B Round Financing
Novogene Technology Co., Ltd., a commercial provider of genomic services, has completed B round financing with banks and venture capital firms in China.
Eisai’s New Treatment For Alzheimer’s Disease Receives FDA Fast Track Approval
The US Food and Drug Administration has granted Fast Track designation for the development of an enzyme that could potentially slow the progression of Alzheimer's Disease.
BeiGene Closes US$200 Million Public Offering
The biopharmaceutical company, which develops immuno-oncology drugs, has announced the closing of its follow-on public offering of 6,250,000 American Depositary Shares.
WuXi Biologics, Prima BioMed To Partner On Manufacturing Cancer Drugs
Under the new agreement, WuXi Biologics will be the exclusive clinical manufacturer of Prima's cancer drugs worldwide.
QUT & Sumitomo Electric To Trial Batteries For Renewable Energy
The joint concentrator photovoltaic project will study large-scale renewable energy generation and storage.
Chemists Synthesize ‘Game-Changing’ Antibiotic Teixobactin
Chemists in Hong Kong have successfully synthesized the newly-discovered antibiotic drug, teixobactin.
Merck Commits €250 Million To Drug Production In China
Merck has inaugurated its Nantong plant in Jiangsu province, its largest manufacturing plant outside of Europe.
Two Genetic Markers Linked To Anti-malarial Drug Resistance
Two genetic markers were strongly associated with the malaria parasite's ability to resist piperaquine, an anti-malarial drug.
